Skip to main content
Top
Published in: BMC Infectious Diseases 1/2006

Open Access 01-12-2006 | Case report

A fatal pseudo-tumour: disseminated basidiobolomycosis

Authors: Guido EL van den Berk, L Arnold Noorduyn, Ruud J van Ketel, Jeannouel van Leeuwen, Willem A Bemelman, Jan M Prins

Published in: BMC Infectious Diseases | Issue 1/2006

Login to get access

Abstract

Background

Basidiobolomycosis is a rare disease caused by the fungus Basidiobolus ranarum, member of the class Zygomycetes, order Entomophthorales, found worldwide. Usually basidiobolomycosis is a subcutaneous infection but rarely gastrointestinal manifestations have been described; 13 adults and 10 children and a few retroperitoneal or pulmonary cases. In gastrointestinal basidiobolomycosis the colon is most frequently involved, usually presenting with subacute mild abdominal pain. In contrast to children only very few described adult patients had hepatic masses. Definitive diagnosis requires culture, serological testing can be helpful. The fungal morphology and the Splendore-Hoeppli phenomenon are characteristic histological features. There are no prominent risk factors. Usually surgery and prolonged antifungal therapy are required.

Case presentation

A 61 year old man presented with progressive left abdominal pain and constipation since a few months. Colonoscopy showed an obstructing tumour in the descending colon, and a hemicolectomy was performed. Histology showed inflammation, possibly caused by a fungal or parasitic infection, without definite identification of an organism. A few weeks postoperatively a CT scan made because of abdominal discomfort, revealed a livermass (6 cm). Treatment with metronidazole, directed against an amoebic liver abscess, was unsuccessful. He developed a marked eosinophilia (27.7%). A liver biopsy was performed and the patient was referred to a university hospital.
A repeated CT scan showed a livermass of 9 cm diameter. Review of colon and liver biopsy samples showed extensive necrosis and histiocytes, multinucleated giant cells and numerous eosinophils. Grocott stained sections contained unusually large hyphae surrounded by strongly eosinophilic material in haematoxylin and eosin stained sections (Splendore-Hoeppli phenomenon). A presumptive diagnosis of Basidiobolus spp. infection was made and treated with amphotericin B (Itraconazol contra-indicated because of renal insufficiency). A few days later the patient died of a septic shock. After autopsy Basidiobolus ranarum was cultured from liver, gallbladder and colon.

Conclusion

Our patient died of gastrointestinal basidiobolomycosis with an obstructing colon tumour and a large hepatic mass. This was a rare presentation of basidiobolomycosis and the second fatal case described worldwide.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sugar AM: Agents of mucormycosis and related species. Mandell, Douglas and Bennetts's principles and practice of infectious diseases. Edited by: Mandell GL, Bennett JE, Dolin R. 2005, Philadelphia, USA: Elsevier, 2973-84. 6 Sugar AM: Agents of mucormycosis and related species. Mandell, Douglas and Bennetts's principles and practice of infectious diseases. Edited by: Mandell GL, Bennett JE, Dolin R. 2005, Philadelphia, USA: Elsevier, 2973-84. 6
2.
go back to reference Marshall Lyon G, Smilack JD, Komatsu KK, Pasha TM, Leighton JA, Guarner J, Colby TV, Lindsley MD, Phelan M, Warnock DW, Hajjeh RA: Clinical and epidemiological characteristics and review of the literature. Clin Infect Dis. 2001, 32: 1448-55. 10.1086/320161.CrossRef Marshall Lyon G, Smilack JD, Komatsu KK, Pasha TM, Leighton JA, Guarner J, Colby TV, Lindsley MD, Phelan M, Warnock DW, Hajjeh RA: Clinical and epidemiological characteristics and review of the literature. Clin Infect Dis. 2001, 32: 1448-55. 10.1086/320161.CrossRef
3.
go back to reference Khan ZU, Khoursheed M, Makar R, Al-Waheeb S, Al-Bader I, Al-Muzaini A, Chandy R, Mustafa AS: Basidiobolus ranarum as an etiologic agent of gastrointestinal zygomycosis. J Clin Microbiol. 2001, 39: 2360-3. 10.1128/JCM.39.6.2360-2363.2001.CrossRefPubMedPubMedCentral Khan ZU, Khoursheed M, Makar R, Al-Waheeb S, Al-Bader I, Al-Muzaini A, Chandy R, Mustafa AS: Basidiobolus ranarum as an etiologic agent of gastrointestinal zygomycosis. J Clin Microbiol. 2001, 39: 2360-3. 10.1128/JCM.39.6.2360-2363.2001.CrossRefPubMedPubMedCentral
4.
go back to reference Yusuf NW, Assaf HM, Rotowa NA: Invasive gastrointestinal Basidiobolus ranarum infection in an immunocompetent child. Pediatr Infect Dis J. 2003, 22: 281-2. 10.1097/00006454-200303000-00017. Yusuf NW, Assaf HM, Rotowa NA: Invasive gastrointestinal Basidiobolus ranarum infection in an immunocompetent child. Pediatr Infect Dis J. 2003, 22: 281-2. 10.1097/00006454-200303000-00017.
5.
go back to reference Al Jarie A, Al-Mohsen I, Al Jumaah S, Al Hazmi M, al Zamil F, Al Zahrani M, Al Modovar E, Al Dayel F, Al Arishii H, Shehrani D, Martins J, Al Mehaidib A, Rossi L, Olaiyan I, Le Quesne G, Al-Mazrou A: Pediatric gastrointestinal basidiobolomycosis. Pediatr Infect Dis J. 2003, 22: 1007-14.CrossRefPubMed Al Jarie A, Al-Mohsen I, Al Jumaah S, Al Hazmi M, al Zamil F, Al Zahrani M, Al Modovar E, Al Dayel F, Al Arishii H, Shehrani D, Martins J, Al Mehaidib A, Rossi L, Olaiyan I, Le Quesne G, Al-Mazrou A: Pediatric gastrointestinal basidiobolomycosis. Pediatr Infect Dis J. 2003, 22: 1007-14.CrossRefPubMed
6.
go back to reference Nazir Z, Hasan R, Pervaiz S, Alam M, Moazam F: Invasive retroperitoneal infection due to Basidiobolus ranarum with response to potassium iodide – case report and review of the literature. Ann Trop Paediatr. 1997, 17: 161-4.PubMed Nazir Z, Hasan R, Pervaiz S, Alam M, Moazam F: Invasive retroperitoneal infection due to Basidiobolus ranarum with response to potassium iodide – case report and review of the literature. Ann Trop Paediatr. 1997, 17: 161-4.PubMed
7.
go back to reference Finelli A, Rasul I, Keystone J, Bargman JM: Development of severe secondary hypertension in a patient with systemic entomophthoromycosis. Am J Kidney Dis. 1997, 29: 620-3.CrossRefPubMed Finelli A, Rasul I, Keystone J, Bargman JM: Development of severe secondary hypertension in a patient with systemic entomophthoromycosis. Am J Kidney Dis. 1997, 29: 620-3.CrossRefPubMed
8.
go back to reference Choonhakarn C, Inthraburan K: Concurrent subcutaneous and visceral basidiobolomycosis in a renal transplant patient. Clin Exp Dermatol. 2004, 29: 369-72. 10.1111/j.1365-2230.2004.01533.x.CrossRefPubMed Choonhakarn C, Inthraburan K: Concurrent subcutaneous and visceral basidiobolomycosis in a renal transplant patient. Clin Exp Dermatol. 2004, 29: 369-72. 10.1111/j.1365-2230.2004.01533.x.CrossRefPubMed
9.
go back to reference Bigliazzi C, Poletti V, Dell'Amore D, Saragoni L, Colby TV: Disseminated basidiobolomycosis in an immunocompetent woman. J Clin Microbiol. 2004, 42: 1367-9. 10.1128/JCM.42.3.1367-1369.2004.CrossRefPubMedPubMedCentral Bigliazzi C, Poletti V, Dell'Amore D, Saragoni L, Colby TV: Disseminated basidiobolomycosis in an immunocompetent woman. J Clin Microbiol. 2004, 42: 1367-9. 10.1128/JCM.42.3.1367-1369.2004.CrossRefPubMedPubMedCentral
10.
Metadata
Title
A fatal pseudo-tumour: disseminated basidiobolomycosis
Authors
Guido EL van den Berk
L Arnold Noorduyn
Ruud J van Ketel
Jeannouel van Leeuwen
Willem A Bemelman
Jan M Prins
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2006
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-6-140

Other articles of this Issue 1/2006

BMC Infectious Diseases 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.